Page 6 - 《中国药房》2026年3期

Clinical observation of triptorelin combined with Biejiajian pill in the treatment of adenomyosis ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ WANG Xiuping，QIAO Xianwei，XU Bing （361）

Pharmacokinetic study of the antidepressant active components from Jiaotai pills in healthy subjects ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ CHEN Yujie，WANG Yiran，LIAO Zhipeng，BIAN Xinfang，WANG Yanjun，JU Wenzheng （366）

Development and evaluation of classification system for drug-related problems in China ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZOU Shuang，LU Tingting，BAO Lei，LIAO Yun，LI Ling，ZHANG Ping （371）

Research on dynamic monitoring of drug consumption based on seasonal Mann-Kendall trend test ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ YU Ziheng，CHEN Chen，YANG Xiangyu，LI Lulu，ZHANG Shaohui （377）
Network meta-analysis of the efficacy and safety of immune checkpoint inhibitors in first-line treatment of
advanced gastric cancer ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ KE Liyuan，WANG Yan，WANG Anping，HUANG Danxue （383）
Umbrella review analysis of the safety and efficacy of vonoprazan in the treatment of peptic ulcers and post-ESD
ulcers ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZHU Qingmei，SHI Min，YANG Dongliang，ZHAO Haixia （389）
Research progress on the intervention of human umbilical cord mesenchymal stem cell in neurodegenerative
disease ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ XU Hongcai，XU Yumin，LIU Shiyu，YAN Huayu，LIU Yuan，YANG Xin，WU Yabo （395）
Progress in mechanistic research on traditional Chinese medicine interventions for irritable bowel syndrome with
diarrhea based on omics technologies ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GAO Shanxue，MA Jiale，PENG Long，CHEN Jie （401）
Mechanism and clinical research progress of calcineurin inhibitor-induced hyperglycemia ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LU Suna，MIN Qiuxia，WEN Xi，ZHANG Ling （407）

CHINA PHARMACY （Semimonthly） Postal Address
Founded in January 1990 Journal Center of Chongqing University Cancer Hospital
Vol.37， No.3， Feb. 2026 129 Daping Main Street，Yuzhong District，Chongqing
Total No.813 Published on Feb. 15，2026 400042，China
Phone
Responsible Institution +86-23-63830521；+86-23-63830907；+86-23-68586727；
National Health Commission，P.R. China +86-23-68586827；+86-23-68573988
Sponsored by E-mail
info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Published by Online Submission
China Pharmacy Editorial Department http：//user.china-pharmacy.com
Director of Editorial Commission Printed by
TIAN Jiazheng Chongqing Changhong Printing Co.， Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China： Chongqing Branch of China Post Group Co.， Ltd.
Deputy Director of Editorial Commission （Code No.78-33）
WANG Ying；WANG Zhiqiang Overseas： China International Book Trading Corporation
Chief of Journal Center （Code No.4703SM）
Subscription Rates
ZOU Xiaoyong CNY 15 per issue；CNY 360 per annum
Editor-in-Chief ISSN 1001-0408
HU Xin CSSN CN 50-1055/R
Deputy Editor-in-Chief CODEN
LENG Huaiming；ZOU Xiaoyong ZYHAA4
Chief Editor Perennial Legal Counsel
XIA Peiyuan Chongqing Huali Wantao Law Firm